Andrey Tolmachov, Enamine CEO (Enamine)

Enam­ine will re­sume op­er­a­tions on lim­it­ed ba­sis, CEO says, as Russ­ian forces with­draw from Ukrain­ian cap­i­tal

As Russ­ian forces with­draw from sev­er­al parts of Ukraine, in­clud­ing the cap­i­tal Kyiv, the firm Enam­ine says it’s get­ting back to work.

The Kyiv-based com­pa­ny, which sev­er­al bio­phar­mas re­ly on to help pro­duce the key in­gre­di­ents that go in­to their ex­per­i­men­tal drugs, put out a state­ment Thurs­day ti­tled sim­ply “Re­sum­ing Work.” CEO An­drey Tol­ma­chov ex­plains that as the sit­u­a­tion in Kyiv slow­ly re­turned to “nor­mal” over the last two weeks, Enam­ine feels as though now is the time to restart op­er­a­tions on a lim­it­ed ba­sis.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.